ADD - How do the two approaches to treating high-risk smoldering multiple myeloma (HRSMM) patients differ? - 101867

Spotlight
Video

ADD - How do the two approaches to treating high-risk smoldering multiple myeloma (HRSMM) patients differ?

Loading........
Description: In this week’s video, Dr. Brian G.M. Durie compares two trials that treat high-risk smoldering multiple myeloma — the CESAR trial and the CENTAURUS trial.

BOTTOM LINE:

The IMF’s Black Swan Research Initiative is excited about the CESAR trial and will conduct future trials in hopes of achieving a cure for myeloma.
Shared By : InternationalMyelomaFoundation
Posted on : 03/06/18
Added : 10 months ago
Category : Multiple Myeloma